Literature DB >> 21375891

Which early 'red flag' symptoms identify children with meningococcal disease in primary care?

Tanya Ali Haj-Hassan1, Matthew J Thompson, Richard T Mayon-White, Nelly Ninis, Anthony Harnden, Lindsay F P Smith, Rafael Perera, David C Mant.   

Abstract

BACKGROUND: Symptoms are part of the initial evaluation of children with acute illness, and are often used to help identify those who may have serious infections. Meningococcal disease is a rapidly progressive infection that needs to be recognised early among children presenting to primary care. AIM: To determine the diagnostic value of presenting symptoms in primary care for meningococcal disease. DESIGN OF STUDY: Data on a series of presenting symptoms were collected using a parental symptoms checklist at point of care for children presenting to a GP with acute infection. Symptom frequencies were compared with existing data on the pre-hospital features of 345 children with meningococcal disease.
SETTING: UK primary care.
METHOD: The study recruited a total of 1212 children aged under 16 years presenting to their GP with an acute illness, of whom 924 had an acute self-limiting infection, including 407 who were reported by parents to be febrile. Symptom frequencies were compared with those reported by parents of 345 children with meningococcal disease. Main outcome measures were diagnostic characteristics of individual symptoms for meningococcal disease.
RESULTS: Five symptoms have clinically useful positive likelihood ratios (LR+) for meningococcal disease: confusion (LR+ = 24.2, 95% confidence interval [CI] = 11.5 to 51.3), leg pain (LR+ = 7.6, 95% CI = 4.9 to 11.9), photophobia (LR+ = 6.5, 95% CI = 3.8 to 11.0), rash (LR+ = 5.5, 95% CI = 4.3 to 7.1), and neck pain/stiffness (LR+ = 5.3, 95% CI = 3.5 to 8.3). Cold hands and feet had limited diagnostic value (LR+ = 2.3, 95% CI = 1.9 to 3.0), while headache (LR+ = 1.0, 95% CI = 0.8 to 1.3), and pale colour (LR+ = 0.3, 95% CI = 0.2 to 0.5) did not discriminate meningococcal disease in children.
CONCLUSION: This study confirms the diagnostic value of classic 'red flag' symptoms of neck stiffness, rash, and photophobia, but also suggests that the presence of confusion or leg pain in a child with an unexplained acute febrile illness should also usually prompt a face-to-face assessment to exclude meningococcal disease. Telephone triage systems and primary care clinicians should consider these as 'red flags' for serious infection.

Entities:  

Mesh:

Year:  2011        PMID: 21375891      PMCID: PMC3047346          DOI: 10.3399/bjgp11X561131

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  17 in total

1.  Diagnostic problems with meningococcal disease in general practice.

Authors:  H T Sørensen; J Møller-Petersen; H B Krarup; H Pedersen; H Hansen; H Hamburger
Journal:  J Clin Epidemiol       Date:  1992-11       Impact factor: 6.437

2.  Enhanced surveillance scheme for suspected meningococcal disease in five regional health authorities in England: 1998.

Authors:  K L Davison; N S Crowcroft; M E Ramsay; N T Begg; E B Kaczmarski; J M Stuart; J M White; H Orr
Journal:  Commun Dis Public Health       Date:  2002-09

3.  Parents' motivation for seeing a physician.

Authors:  Ruth Kirk Ertmann; Margareta Söderström; Susanne Reventlow
Journal:  Scand J Prim Health Care       Date:  2005-09       Impact factor: 2.581

4.  The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases.

Authors:  Nelly Ninis; Claire Phillips; Linda Bailey; Jon I Pollock; Simon Nadel; Joseph Britto; Ian Maconochie; Andrew Winrow; Pietro G Coen; Robert Booy; Michael Levin
Journal:  BMJ       Date:  2005-06-25

5.  'Do I don't I call the doctor': a qualitative study of parental perceptions of calling the GP out-of-hours.

Authors:  Anna M. Houston; Ann J. Pickering
Journal:  Health Expect       Date:  2000-12       Impact factor: 3.377

6.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

Authors:  Caroline L Trotter; Nick J Andrews; Edward B Kaczmarski; Elizabeth Miller; Mary E Ramsay
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

7.  Extremity pain and refusal to walk in children with invasive meningococcal disease.

Authors:  Stanley H Inkelis; Daniel O'Leary; Vincent J Wang; Richard Malley; Martha K Nicholson; Nathan Kuppermann
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

8.  Parents' beliefs and expectations when presenting with a febrile child at an out-of-hours general practice clinic.

Authors:  Per Kallestrup; Flemming Bro
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

Review 9.  Recognizing meningococcal disease: the case for further research in primary care.

Authors:  S Granier; P Owen; N C Stott
Journal:  Br J Gen Pract       Date:  1998-04       Impact factor: 5.386

10.  Serious infections in children: an incidence study in family practice.

Authors:  Ann Van den Bruel; Stefaan Bartholomeeusen; Bert Aertgeerts; Carla Truyers; Frank Buntinx
Journal:  BMC Fam Pract       Date:  2006-03-28       Impact factor: 2.497

View more
  10 in total

Review 1.  Research into practice: acutely ill children.

Authors:  Ann Van den Bruel; Matthew Thompson
Journal:  Br J Gen Pract       Date:  2014-06       Impact factor: 5.386

2.  Clinical predictors of antibiotic prescribing for acutely ill children in primary care: an observational study.

Authors:  Kathryn O'Brien; Thomas Wyn Bellis; Mark Kelson; Kerenza Hood; Christopher C Butler; Adrian Edwards
Journal:  Br J Gen Pract       Date:  2015-09       Impact factor: 5.386

3.  When and how do GPs record vital signs in children with acute infections? A cross-sectional study.

Authors:  Claire Blacklock; Tanya Ali Haj-Hassan; Matthew J Thompson
Journal:  Br J Gen Pract       Date:  2012-10       Impact factor: 5.386

4.  Diagnosis and management of bacterial meningitis in the paediatric population: a review.

Authors:  Catherine L Tacon; Oliver Flower
Journal:  Emerg Med Int       Date:  2012-09-20       Impact factor: 1.112

5.  Severe hand, foot and mouth disease in Shenzhen, South China: what matters most?

Authors:  J Mou; M Dawes; Y Li; Y He; H Ma; X Xie; S Griffiths; J Cheng
Journal:  Epidemiol Infect       Date:  2013-07-01       Impact factor: 4.434

6.  A systematic review of the organizational, environmental, professional and child and family factors influencing the timing of admission to hospital for children with serious infectious illness.

Authors:  Bernie Carter; Damian Roland; Lucy Bray; Jane Harris; Poornima Pandey; Jo Fox; Enitan D Carrol; Sarah Neill
Journal:  PLoS One       Date:  2020-07-23       Impact factor: 3.240

7.  Nonspecific symptoms dominate at first contact to emergency healthcare services among cases with invasive meningococcal disease.

Authors:  Nichlas Hovmand; Helle Collatz Christensen; Lene Fogt Lundbo; Håkon Sandholdt; Gitte Kronborg; Perle Darsø; Jacob Anhøj; Stig Nikolaj Fasmer Blomberg; Asmus Thun Bisgaard; Thomas Benfield
Journal:  BMC Fam Pract       Date:  2021-11-30       Impact factor: 2.497

8.  Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.

Authors:  Catherine Weil-Olivier; Muhamed-Kheir Taha; Stéphane Bouée; Corinne Emery; Véronique Loncle-Provot; Gaëlle Nachbaur; Ekkehard Beck; Céline Pribil
Journal:  Hum Vaccin Immunother       Date:  2022-02-22       Impact factor: 3.452

9.  Carers' perspectives on the presentation of community-acquired pneumonia and empyema in children: a case series.

Authors:  Joanna C Crocker; Meirion R Evans; Christopher C Butler; Kerenza Hood; Colin V E Powell
Journal:  BMJ Open       Date:  2012-09-04       Impact factor: 2.692

Review 10.  Care of the patient with invasive meningococcal disease by prehospital emergency medical service clinicians: a scoping review.

Authors:  James Pearce; Micah Peters; Nikki May; Helen Marshall; Cindy Hein; Hugh Grantham
Journal:  BMJ Open       Date:  2020-02-28       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.